NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market today that its third quarter revenues were up 13 percent year over year to $27.0 million from $23.9 million in Q3 2016.

In a preliminary report last month, the company estimated that it would end up with between $25.9 million and $26.9 million in total revenues for the third quarter of 2017, including product and service revenue of approximately $16.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.